11/07/2024
7:15 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2024
3:01 PM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2024
8:16 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024
7:40 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/08/2024
7:59 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024
6:15 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/10/2024
3:00 PM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K/A | |
|
09/10/2024
7:15 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2024
7:10 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024
7:40 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024
6:28 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
07/31/2024
6:15 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form NT 20-F | |
07/05/2024
6:15 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2024
6:30 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/10/2024
6:01 AM | LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
6:45 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024
3:30 PM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2024
3:16 PM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/08/2024
7:32 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 424B3 | |
04/29/2024
7:15 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
7:03 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024
7:15 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024
7:20 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/03/2024
7:10 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/05/2024
7:06 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/23/2024
7:15 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
5:17 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/16/2024
7:25 PM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/16/2024
3:14 PM | YS Biopharma Co., Ltd. (Subject)
YS Biopharma Co., Ltd. (Subject)
Lakeshore Biopharma (Subject)
Zhang /MD Yi (Filed by)
| Form SC 13G/A | |
02/14/2024
10:23 AM | Wong Fung Ching (Filed by)
YS Biopharma Co., Ltd. (Subject)
YS Biopharma Co., Ltd. (Subject)
Lakeshore Biopharma (Subject)
| Form SC 13D | |
02/14/2024
6:59 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
7:01 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
7:05 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/09/2024
6:10 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/25/2024
11:15 PM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form EFFECT | |
01/26/2024
5:03 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/23/2024
3:18 PM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form POS AM | |
01/22/2024
4:10 PM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
6:10 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023
11:43 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
5:37 AM | YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Lakeshore Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Shocking footage from Bill Gates’ $100,000,000,000 AI Bet (Ad) If you missed out on Nvidia, watch this video I just made. Click here for full details. |
